VUSs predicted to be pathogenic—particularly in genes like KEAP1 and SMARCA4—are consistently associated with poorer overall survival in two nonoverlapping non-small cell lung cancer cohorts, and tend to be mutually exclusive with other known oncogenic alterations within the same pathways. Here, KEAP1 is linked to non-small cell lung carcinoma.